XML 35 R28.htm IDEA: XBRL DOCUMENT v3.25.1
Nature of Business - Additional Information (Details) - USD ($)
$ in Thousands
3 Months Ended
Dec. 31, 2025
Feb. 28, 2025
Mar. 31, 2025
Mar. 31, 2024
Dec. 31, 2024
Cash, cash equivalents and short-term investments     $ 24,600    
Net Income (Loss)     (5,042) $ 130  
Accumulated deficit     (164,806)   $ (159,764)
Consideration Transferred     29,400    
Proceeds from issuance of notes     9,766 0  
Total operating expenses     $ 6,497 $ 5,767  
Loan Agreement          
Gross proceeds from loan agreement   $ 10,000      
CalciMedica          
Percentage of ownership of common stock     72.00%    
Graybug          
Percentage of ownership of common stock     28.00%    
Convertible Debt [Member]          
Proceeds from issuance of notes     $ 18,300    
Common Stock [Member]          
Stock issued 591,595   490,073    
Preferred and Common stock [Member]          
Total net proceeds     $ 141,700